Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Ibrutinib-related atrial fibrillation: Therapeutic challenges.

Kapelios CJ, Bonou MS, Diamantopoulos P, Angelopoulou MK, Masoura C, Barbetseas J, Viniou NA.

J Oncol Pharm Pract. 2018 Jan 1:1078155218785983. doi: 10.1177/1078155218785983. [Epub ahead of print]

PMID:
30012045
2.

Ultrafast Multiplexed-Allergen Detection through Advanced Fluidic Design and Monolithic Interferometric Silicon Chips.

Angelopoulou M, Petrou PS, Makarona E, Haasnoot W, Moser I, Jobst G, Goustouridis D, Lees M, Kalatzi K, Raptis I, Misiakos K, Kakabakos SE.

Anal Chem. 2018 Jul 12. doi: 10.1021/acs.analchem.8b02321. [Epub ahead of print]

PMID:
29999303
3.

Experiential learning in oral health education.

Angelopoulou MV, Kavvadia K.

J Educ Health Promot. 2018 Jun 12;7:70. doi: 10.4103/jehp.jehp_180_17. eCollection 2018. Review.

4.

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.

Kalpadakis C, Pangalis GA, Sachanas S, Tsirkinidis P, Kontopidou FN, Moschogiannis M, Yiakoumis X, Koulieris E, Dimopoulou MN, Kokkoris SI, Kyrtsonis MC, Siakantaris MP, Tsourouflis G, Korkolopoulou P, Rontogianni D, Tsaftaridis P, Plata E, Papadaki HA, Panagiotidis P, Angelopoulou MK, Vassilakopoulos TP.

Blood. 2018 Jun 18. pii: blood-2018-02-833608. doi: 10.1182/blood-2018-02-833608. [Epub ahead of print] No abstract available.

PMID:
29914978
5.

Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.

Tsirigotis P, Vassilakopoulos T, Batsis I, Bousiou Z, Gkirkas K, Sakellari I, Kaloyannidis P, Roussou P, Pangalis GA, Moschogiannis M, Vassilopoulos G, Repousis P, Megalakaki A, Michalis E, Kalpadakis C, Papadaki HA, Kotsianidis I, Hatzimichael E, Spyridonidis A, Anargyrou K, Poulakidas E, Giannoullia P, Apostolidis I, Stamouli M, Konstantopoulos K, Pappa V, Panayiotidis P, Harhalakis N, Anagnostopoulos A, Angelopoulou M.

Hematol Oncol. 2018 Jun 8. doi: 10.1002/hon.2521. [Epub ahead of print]

PMID:
29882363
6.

Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?

Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Vassilakopoulos TP.

Best Pract Res Clin Haematol. 2018 Mar;31(1):65-72. doi: 10.1016/j.beha.2017.10.011. Epub 2017 Nov 7. Review.

PMID:
29452668
7.

Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation.

Boutsikas G, Terpos E, Papatheodorou A, Tsirkinidis P, Tsirigotis P, Meletiou A, Lalou E, Telonis V, Zannou A, Kanellopoulos A, Galani Z, Stefanou A, Tsaftaridis P, Viniou NA, Panayiotidis P, Kyrtsonis MC, Meletis J, Vassilakopoulos TP, Angelopoulou MK.

Eur J Haematol. 2018 Feb;100(2):131-139. doi: 10.1111/ejh.12990. Epub 2017 Dec 4.

PMID:
29105864
8.

The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials.

Angelopoulou MK, Mosa E, Pangalis GA, Rondogianni P, Chatziioannou S, Prassopoulos V, Moschogianni M, Tsirkinidis P, Asimakopoulos JV, Konstantinou I, Tsourouflis G, Sachanas S, Yiakoumis X, Boutsikas G, Arapaki M, Gainaru G, Kyrtsonis MC, Siakantaris MP, Datseris I, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP.

Anticancer Res. 2017 Oct;37(10):5727-5736.

PMID:
28982893
9.

Protein Z (PZ) and plasminogen activator inhibitor-1 (PAI-1) plasma levels in patients with previously untreated Hodgkin lymphoma (HL).

Boutsikas G, Terpos E, Markopoulos A, Papatheodorou A, Stefanou A, Georgiou G, Galani Z, Komninaka V, Telonis V, Anagnostopoulos I, Dimitrakopoulou L, Anargyrou K, Tsionos K, Christoulas D, Gonianaki M, Giannikos T, Kokoris S, Konstantopoulos K, Meletis J, Angelopoulou MK, Travlou A, Vassilakopoulos TP.

J BUON. 2017 Jul-Aug;22(4):1022-1031.

PMID:
28952223
10.

Bone metabolism markers and angiogenic cytokines as regulators of human hematopoietic stem cell mobilization.

Tsirkinidis P, Terpos E, Boutsikas G, Papatheodorou A, Anargyrou K, Lalou E, Dimitrakopoulou A, Kalpadakis C, Konstantopoulos K, Siakantaris M, Panayiotidis P, Pangalis G, Kyrtsonis MC, Vassilakopoulos T, Angelopoulou MK.

J Bone Miner Metab. 2018 Jul;36(4):399-409. doi: 10.1007/s00774-017-0853-4. Epub 2017 Jun 28.

PMID:
28660376
11.

Tumor Protein 53 Gene Mutations Without 17p13 Deletion Have No Significant Clinical Implications in Chronic Lymphocytic Leukemia. Detection of a New Mutation.

Diamantopoulos PT, Samara S, Kollia P, Giannakopoulou N, Sofotasiou M, Kalala F, Kodandreopoulou E, Zervakis P, Vassilakopoulos T, Siakantaris M, Mantzourani M, Angelopoulou M, Kyrtshonis MC, Korkolopoulou P, Patsouris E, Viniou NA.

Anticancer Res. 2017 May;37(5):2387-2391.

PMID:
28476805
12.

Treatment of splenic marginal zone lymphoma.

Kalpadakis C, Pangalis GA, Angelopoulou MK, Vassilakopoulos TP.

Best Pract Res Clin Haematol. 2017 Mar - Jun;30(1-2):139-148. doi: 10.1016/j.beha.2016.07.004. Epub 2016 Nov 4. Review.

PMID:
28288709
13.

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.

Angelopoulou MK, Vassilakopoulos TP, Batsis I, Sakellari I, Gkirkas K, Pappa V, Giannoulia P, Apostolidis I, Apostolopoulos C, Roussou P, Panayiotidis P, Dimou M, Kyrtsonis MC, Palassopoulou M, Vassilopoulos G, Moschogiannis M, Kalpadakis C, Margaritis D, Spyridonidis A, Michalis E, Anargyrou K, Repousis P, Hatzimichael E, Bousiou Z, Poulakidas E, Grentzelias D, Harhalakis N, Pangalis GA, Anagnostopoulos A, Tsirigotis P.

Hematol Oncol. 2018 Feb;36(1):174-181. doi: 10.1002/hon.2383. Epub 2017 Feb 20.

14.

Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?

Vassilakopoulos TP, Asimakopoulos JV, Plata E, Kelepesis G, Petevi K, Koutsi C, Papageorgiou L, Tsaftaridis P, Angelopoulou MK, Konstantopoulos K, Meletis J.

Leuk Lymphoma. 2017 Jul;58(7):1743-1746. doi: 10.1080/10428194.2016.1253838. Epub 2016 Dec 6. No abstract available.

PMID:
27919176
15.

Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).

Kalpadakis C, Pangalis GA, Vassilakopoulos TP, Roumelioti M, Sachanas S, Korkolopoulou P, Koulieris E, Moschogiannis M, Yiakoumis X, Tsirkinidis P, Pontikoglou C, Rondoyianni D, Papadaki HA, Panayiotidis P, Angelopoulou MK.

Hematol Oncol. 2017 Dec;35(4):542-547. doi: 10.1002/hon.2361. Epub 2016 Oct 13.

PMID:
27734522
16.

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.

Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V, Schneider M, Yoshida K, Skaftason A, Pandzic T, Gonzalez B, Tasidou A, Waldhueter N, Rivas-Delgado A, Angelopoulou M, Ziepert M, Arends CM, Couronné L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J, Dörken B, Drexler HG, Roos-Weil D, Schmitt CA, Munch-Petersen HD, Zenz T, Hansmann ML, Strefford JC, Enblad G, Bernard OA, Ralfkiaer E, Erlanson M, Korkolopoulou P, Hultdin M, Papadaki T, Grønbæk K, Lopez-Guillermo A, Ogawa S, Küppers R, Stamatopoulos K, Stavroyianni N, Kanellis G, Rosenwald A, Campo E, Amini RM, Ott G, Vassilakopoulos TP, Hummel M, Rosenquist R, Damm F.

Blood. 2016 Dec 8;128(23):2666-2670. Epub 2016 Sep 26.

17.

Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib.

Angelopoulou MK, Asimakopoulos JV, Galani Z, Levidou G, Roumelioti M, Vassilakopoulos TP, Korkolopoulou P, Panayiotidis P.

Blood Cancer J. 2016 Aug 26;6(8):e461. doi: 10.1038/bcj.2016.66. No abstract available.

18.

Prognostic factors in Hodgkin lymphoma.

Bröckelmann PJ, Angelopoulou MK, Vassilakopoulos TP.

Semin Hematol. 2016 Jul;53(3):155-64. doi: 10.1053/j.seminhematol.2016.05.003. Epub 2016 May 12. Review.

PMID:
27496306
19.

Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemia.

Diamantopoulos PT, Sofotasiou M, Georgoussi Z, Giannakopoulou N, Papadopoulou V, Galanopoulos A, Kontandreopoulou E, Zervakis P, Pallaki P, Kalala F, Kyrtsonis MC, Dimitrakopoulou A, Vassilakopoulos T, Angelopoulou M, Spanakis N, Viniou NA.

Cancer Med. 2016 Sep;5(9):2240-8. doi: 10.1002/cam4.804. Epub 2016 Jul 1.

20.

Lab-on-a-Membrane Foldable Devices for Duplex Drop-Volume Electrochemical Biosensing Using Quantum Dot Tags.

Kokkinos C, Angelopoulou M, Economou A, Prodromidis M, Florou A, Haasnoot W, Petrou P, Kakabakos S.

Anal Chem. 2016 Jul 5;88(13):6897-904. doi: 10.1021/acs.analchem.6b01625. Epub 2016 Jun 14.

PMID:
27257985
21.

Response to 'PET after response to R-CHOP in primary mediastinal large B-cell lymphoma'.

Vassilakopoulos TP, Papageorgiou S, Pangalis GA, Chatziioannou S, Angelopoulou MK, Panayiotidis P, Konstantopoulos K, Rondogianni P.

Leukemia. 2016 Aug;30(8):1800-1. doi: 10.1038/leu.2016.109. Epub 2016 Jun 3. No abstract available.

PMID:
27256701
22.

No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.

Kalpadakis C, Pangalis GA, Sachanas S, Rontogianni D, Korkolopoulou P, Milionis V, Vassilakopoulos TP, Papadaki HA, Angelopoulou MK.

Leuk Lymphoma. 2016 Nov;57(11):2705-8. doi: 10.3109/10428194.2016.1157877. Epub 2016 Apr 15. No abstract available.

PMID:
27082039
23.

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases.

Tofas P, Skiada A, Angelopoulou M, Sipsas N, Pavlopoulou I, Tsaousi S, Pagoni M, Kotsopoulou M, Perlorentzou S, Antoniadou A, Pirounaki M, Skoutelis A, Daikos GL.

Int J Antimicrob Agents. 2016 Apr;47(4):335-9. doi: 10.1016/j.ijantimicag.2016.01.011. Epub 2016 Feb 26.

PMID:
27005460
24.

Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.

Vassilakopoulos TP, Dimopoulou MN, Angelopoulou MK, Petevi K, Pangalis GA, Moschogiannis M, Dimou M, Boutsikas G, Kanellopoulos A, Gainaru G, Plata E, Flevari P, Koutsi K, Papageorgiou L, Telonis V, Tsaftaridis P, Sachanas S, Yiakoumis X, Tsirkinidis P, Viniou NA, Siakantaris MP, Variami E, Kyrtsonis MC, Meletis J, Panayiotidis P, Konstantopoulos K.

Oncologist. 2016 Mar;21(3):343-53. doi: 10.1634/theoncologist.2015-0251. Epub 2016 Feb 26.

25.

Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.

Lakiotaki E, Levidou G, Angelopoulou MK, Adamopoulos C, Pangalis G, Rassidakis G, Vassilakopoulos T, Gainaru G, Flevari P, Sachanas S, Saetta AA, Sepsa A, Moschogiannis M, Kalpadakis C, Tsesmetzis N, Milionis V, Chatziandreou I, Thymara I, Panayiotidis P, Dimopoulou M, Plata E, Konstantopoulos K, Patsouris E, Piperi C, Korkolopoulou P.

Sci Rep. 2016 Feb 19;6:21252. doi: 10.1038/srep21252.

26.

Removable partial dentures vs overdentures in children with ectodermal dysplasia: two case reports.

Maroulakos G, Artopoulou II, Angelopoulou MV, Emmanouil D.

Eur Arch Paediatr Dent. 2016 Jun;17(3):205-10. doi: 10.1007/s40368-015-0212-x. Epub 2015 Dec 8.

PMID:
26645986
27.

Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial".

Vassilakopoulos TP, Apostolidis J, Angelopoulou MK.

Haematologica. 2015 Nov;100(11):e480-1. doi: 10.3324/haematol.2015.133223. No abstract available.

28.

Oral Hygiene Facilitators and Barriers in Greek 10 Years Old Schoolchildren.

Angelopoulou M, Kavvadia K, Oulis C, Reppa C.

Int J Clin Pediatr Dent. 2015 May-Aug;8(2):87-93. doi: 10.5005/jp-journals-10005-1290. Epub 2015 Aug 11. Review.

29.

Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia.

Papadopoulou V, Kontandreopoulou E, Panayiotidis P, Roumelioti M, Angelopoulou M, Kyriazopoulou L, Diamantopoulos PT, Vaiopoulos G, Variami E, Kotsianidis I, Athina Viniou N.

Leuk Lymphoma. 2016 May;57(5):1182-8. doi: 10.3109/10428194.2015.1090573. Epub 2015 Dec 23.

PMID:
26373709
30.

Chemical and Biological Investigation of Olive Mill Waste Water - OMWW Secoiridoid Lactones.

Vougogiannopoulou K, Angelopoulou MT, Pratsinis H, Grougnet R, Halabalaki M, Kletsas D, Deguin B, Skaltsounis LA.

Planta Med. 2015 Aug;81(12-13):1205-12. doi: 10.1055/s-0035-1546243. Epub 2015 Jul 28.

PMID:
26218340
31.

Significance of the detection of paroxysmal nocturnal hemoglobinuria clones in patients with multiple myeloma undergoing autologous stem cell transplantation.

Chatziantoniou V, Alexia S, Konstantopoulos K, Repousis P, Megalakaki A, Kotsopoulou M, Kylidou P, Vassilakopoulos T, Angelopoulou MK.

Hematol Oncol Stem Cell Ther. 2015 Dec;8(4):150-9. doi: 10.1016/j.hemonc.2015.06.008. Epub 2015 Jul 9.

32.

A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.

Sakellari I, Angelopoulou M, Tsopra O, Dervenoulas I, Tsirigotis P, Spyridonidis A, Liga M, Tsionos K, Anargyrou K, Pouli A, Anagnostopoulos A.

Ann Hematol. 2015 Oct;94(10):1733-40. doi: 10.1007/s00277-015-2437-5. Epub 2015 Jul 5.

PMID:
26141369
33.

Induced ankylosis of a primary molar for skeletal anchorage in the mandible as alternative to mini-implants.

Angelopoulou MV, Koletsi D, Vadiakas G, Halazonetis DJ.

Prog Orthod. 2015;16:18. doi: 10.1186/s40510-015-0090-0. Epub 2015 Jun 18.

34.

High Frequency of Thyroid Disorders in Patients Presenting With Neutropenia to an Outpatient Hematology Clinic STROBE-Compliant Article.

Kyritsi EM, Yiakoumis X, Pangalis GA, Pontikoglou C, Pyrovolaki K, Kalpadakis C, Mavroudi I, Koutala H, Mastrodemou S, Vassilakopoulos TP, Vaiopoulos G, Diamanti-Kandarakis E, Papadaki HA, Angelopoulou MK.

Medicine (Baltimore). 2015 Jun;94(23):e886. doi: 10.1097/MD.0000000000000886.

35.

Congenital adrenal hyperplasia: a case report with premature teeth exfoliation and bone resorption.

Angelopoulou MV, Kontogiorgos E, Emmanouil D.

Pediatrics. 2015 Jun;135(6):e1524-9. doi: 10.1542/peds.2014-3577.

36.

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.

Vassilakopoulos TP, Pangalis GA, Chatziioannou S, Papageorgiou S, Angelopoulou MK, Galani Z, Kourti G, Prassopoulos V, Leonidopoulou T, Terpos E, Dimopoulou MN, Sachanas S, Kalpadakis C, Konstantinidou P, Boutsis D, Stefanoudaki E, Kyriazopoulou L, Siakantaris MP, Kyrtsonis MC, Variami E, Kotsianidis I, Symeonidis A, Michali E, Katodritou E, Kokkini G, Tsatalas C, Papadaki H, Dimopoulos MA, Sotiropoulos V, Pappa V, Karmiris T, Meletis J, Apostolidis J, Datseris I, Panayiotidis P, Konstantopoulos K, Roussou P, Rondogianni P.

Leukemia. 2016 Jan;30(1):238-42. doi: 10.1038/leu.2015.120. Epub 2015 May 14. No abstract available.

PMID:
25971363
37.
38.

Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) with concurrent high grade component at diagnosis: clinico-pathologic features and treatment strategy.

Sachanas S, Pangalis GA, Kalpadakis C, Levidou G, Yiakoumis X, Moschogiannis M, Kyrtsonis MC, Vassilakopoulos TP, Tsirkinidis P, Siakantaris M, Spiliadi C, Karagianni E, Korkolopoulou P, Rontogianni D, Papadaki H, Panayiotidis P, Angelopoulou M.

Leuk Lymphoma. 2015;56(11):3230-2. doi: 10.3109/10428194.2015.1034698. Epub 2015 May 12. No abstract available.

PMID:
25827212
39.

Transformed nodal marginal zone lymphoma versus diffuse large B cell lymphoma: the microRNA aspect.

Angelopoulou MK.

Acta Haematol. 2015;133(2):212-3. doi: 10.1159/000365878. Epub 2014 Nov 4. No abstract available.

PMID:
25378123
40.

Gastric involvement in patients with primary mediastinal large B-cell lymphoma.

Papageorgiou SG, Sachanas S, Pangalis GA, Tsopra O, Levidou G, Foukas P, Rondogianni P, Sotiropoulos V, Ioannidou HD, Gassiamis A, Iliakis T, Korkolopoulou P, Angelopoulou MK, Pappa V, Konstantopoulos K, Vassilakopoulos TP.

Anticancer Res. 2014 Nov;34(11):6717-23.

PMID:
25368280
41.

New insights into monoclonal B-cell lymphocytosis.

Kalpadakis C, Pangalis GA, Sachanas S, Vassilakopoulos TP, Kyriakaki S, Korkolopoulou P, Koulieris E, Moschogiannis M, Yiakoumis X, Tsirkinidis P, Kyrtsonis MC, Levidou G, Papadaki HA, Panayiotidis P, Angelopoulou MK.

Biomed Res Int. 2014;2014:258917. doi: 10.1155/2014/258917. Epub 2014 Sep 11. Review.

42.

Clinical aspects of malt lymphomas.

Kalpadakis C, Pangalis GA, Vassilakopoulos TP, Kyriakaki S, Yiakoumis X, Sachanas S, Moschogiannis M, Tsirkinidis P, Korkolopoulou P, Papadaki HA, Angelopoulou MK.

Curr Hematol Malig Rep. 2014 Sep;9(3):262-72. doi: 10.1007/s11899-014-0218-1. Review.

PMID:
25240474
43.

The catabolic effect of TNFα on bovine nucleus pulposus intervertebral disc cells and the restraining role of glucosamine sulfate in the TNFα-mediated up-regulation of MMP-3.

Mavrogonatou E, Angelopoulou MT, Kletsas D.

J Orthop Res. 2014 Dec;32(12):1701-7. doi: 10.1002/jor.22725. Epub 2014 Sep 12.

44.

New insights in the mobilization of hematopoietic stem cells in lymphoma and multiple myeloma patients.

Angelopoulou MK, Tsirkinidis P, Boutsikas G, Vassilakopoulos TP, Tsirigotis P.

Biomed Res Int. 2014;2014:835138. doi: 10.1155/2014/835138. Epub 2014 Aug 14. Review.

45.

Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemia.

Kyrtsonis MC, Sarris K, Koulieris E, Maltezas D, Nikolaou E, Angelopoulou MK, Bartzis V, Tzenou T, Dimou M, Siakandaris MP, Viniou NA, Sachanas S, Kalpadakis C, Sfikakis PP, Pangalis GA, Panayiotidis P.

Biomed Res Int. 2014;2014:159632. doi: 10.1155/2014/159632. Epub 2014 Aug 6.

46.

School-based oral health-education program using experiential learning or traditional lecturing in adolescents: a clinical trial.

Angelopoulou MV, Oulis CJ, Kavvadia K.

Int Dent J. 2014 Oct;64(5):278-84. doi: 10.1111/idj.12123. Epub 2014 Aug 21.

PMID:
25142752
47.

Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis,  Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.

Levidou G, Sachanas S, Pangalis GA, Kalpadakis C, Yiakoumis X, Moschogiannis M, Sepsa A, Lakiotaki E, Milionis V, Kyrtsonis MC, Vassilakopoulos TP, Tsirkinidis P, Kontopidou F, Kokoris S, Siakantaris M, Angelopoulou M, Papadaki H, Kavantzas N, Panayiotidis P, Patsouris E, Korkolopoulou P.

Biomed Res Int. 2014;2014:251479. doi: 10.1155/2014/251479. Epub 2014 May 5.

48.

Effects of anthracyclines on aortic distensibility in patients with lymphomas: a prospective study.

Daskalaki M, Makris T, Vassilakopoulos T, Moyssakis I, Siakantaris M, Angelopoulou M, Papadogiannis D, Vaiopoulos G, Pangalis G.

Hellenic J Cardiol. 2014 May-Jun;55(3):191-6.

49.

Expression of three different ATP-binding cassette transporters and correlation to chemoresistance in acute myeloid leukemia.

Palaiologou D, Panayiotidis P, Papanikolaou G, Georgiou G, Boutsikas G, Hatzinicolaou SL, Pangalis GA, Sakellaropoulos N, Vassilakopoulos TP, Angelopoulou MK.

Int J Lab Hematol. 2015 Feb;37(1):e7-e10. doi: 10.1111/ijlh.12249. Epub 2014 May 9. No abstract available.

PMID:
24809224
50.

The differential proliferative response of fetal and adult human skin fibroblasts to TGF-β is retained when cultured in the presence of fibronectin or collagen.

Armatas AA, Pratsinis H, Mavrogonatou E, Angelopoulou MT, Kouroumalis A, Karamanos NK, Kletsas D.

Biochim Biophys Acta. 2014 Aug;1840(8):2635-42. doi: 10.1016/j.bbagen.2014.04.004. Epub 2014 Apr 13.

PMID:
24735795

Supplemental Content

Loading ...
Support Center